NEWS
< back to news list

From idea to commercialization: NanoGroup and A4BEE at the InternanoPoland 2024 conference

During the InternanoPoland 2024 conference in Katowice, Julia Zakrzewska from NanoGroup and Łukasz Paciorkowski and Maciej Gaik from A4BEE presented a fascinating process of development and commercialization of medical inventions, based on the example of the NanOX system. This presentation was not only an opportunity to present groundbreaking technologies, but also to have a broader discussion about the state of medical innovation and the future of science in Poland.

One of the main goals of the NanOX system is to increase the availability of organs for transplantation, which could revolutionize transplantology. Thanks to modern technologies such as NanOX, research in this field is taking on a new dimension.

– Imagine a blood-like fluid using nanotechnology and a device that simulates the functions of the human body. This not only allows the organ to be kept alive for transplantation, but also supports its regeneration. In the future, this will allow the treatment of organs before their transplantation. This is a reality that we are working on – said Julia Zakrzewska during the conference.

NanOX is a unique system for organ storage and perfusion,

which can significantly increase the number of organs available for transplantation and increase the effectiveness of the operations themselves. In their presentation titled “Case Study on Commercialization of the NanOX Transplantation System,” the experts discussed how this system, developed by NanoGroup in collaboration with A4BEE, is getting closer to commercialization.

During the presentation, the speakers emphasized that the success of medical inventions depends not only on the knowledge of researchers, but also on strategic partnerships that provide stable financing and support the transformation of innovative ideas into real products ready for the market.

– Thanks to the work of the team led by Wojciech Frąckowiak, we are taking further steps towards transforming the vision into reality. A4BEE as a technology partner supports NanoGroup in the commercialization of the NanOX system, and the third prototype of the NanOX Recovery Box device has already passed operational tests. The next stage will be to prepare the device for certification! – said Łukasz Paciorkowski from A4BEE.

We thank the organizers of InternanoPoland for the excellent organization and world-class level of the conference. The mission of transforming transplantology continues – keep your fingers crossed!

Copyright © NanoGroup 2024

Prof. Tomasz Ciach

Founder, Member of the Management Board of NANOGROUP S.A.

Nanotechnology expert. Professor at the Faculty of Chemical and Processing Engineering, Warsaw University of Technology, head of the Biotechnology and Bioprocessing Division. Author of two technologies that are already in production stage, 12 granted patents and over 50 publications. Founder of BioMedLab research group, consultant in numerous companies (AstraZeneca, Procter and Gamble, Reckit, Adamed, Balton, Galmed). Work on various aspects of Biomedical Engineering, mostly on biomedical nanotechnology, active coatings for medical implants, nanoparticles for cancer treatment, biodegradable and nonbiodegradable implants, bone and vascular prosthesis. He gives rare, but already brilliant example of how brave ideas become socially and financially valuable.

Piotr Mierzejewski

Vice President of the Management Board of NANOGROUP S.A.

Clinical pharmacology specialist, former advisor to the Minister of Health on drug policy. He negotiated Poland’s accession to the EU in the field of pharmacy, responsible for the implementation of EU directives in the field of pharmacy into the Polish legal system. Co-founder of the Office for Registration of Medicinal Products, Medical Devices and Biocidal Products. Owner of a consulting company cooperating with international pharmaceutical companies in the field of introducing new technologies to the Polish market.

Przemysław Mazurek

President of the Management Board of NANOGROUP S.A.

Associated with the health market since 2004. As Managing Director, he restructured and developed the most dynamically operating Medical Center in the Podkarpacie region, creating and setting new standards of customer service quality on the market. Co-creator of the first solution in Poland for online registration of medical appointments. Co-founder of the first and only Infertility Treatment Clinic (MEDICOR) in Podkarpacie, which he headed as the President until 2009. He was responsible for the development of health insurance in the PZU Group. As Vice President of PZU Pomoc S.A. created the largest medical TPA in Poland to handle health insurance. Co-founder of the first drug insurance in Poland. Since 2015, he has been active in the field of Wealth Management and advises on management and finance. A graduate of International Economic and Political Relations as well as Management and Marketing at the Warsaw School of Economics.

Przemysław Mazurek

President of the Management Board of NANOGROUP S.A.

Associated with the health market since 2004. As Managing Director, he restructured and developed the most dynamically operating Medical Center in the Podkarpacie region, creating and setting new standards of customer service quality on the market. Co-creator of the first solution in Poland for online registration of medical appointments. Co-founder of the first and only Infertility Treatment Clinic (MEDICOR) in Podkarpacie, which he headed as the President until 2009. He was responsible for the development of health insurance in the PZU Group. As Vice President of PZU Pomoc S.A. created the largest medical TPA in Poland to handle health insurance. Co-founder of the first drug insurance in Poland. Since 2015, he has been active in the field of Wealth Management and advises on management and finance. A graduate of International Economic and Political Relations as well as Management and Marketing at the Warsaw School of Economics.